INBP (Integrated Biopharma) E10: $0.09 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

INBP Integrated Biopharma Inc INBP
36 GF Score
Price $0.16
GF Value $0.26
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Integrated Biopharma E10?

Integrated Biopharma INBP 36 E10 is $0.09 as of Mar. 2026. GuruFocus rates INBP with a GF Score™ of 36/100 and a GF Value™ of $0.26 (Possible Value Trap). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Integrated Biopharma's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.09 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 4.00% per year. During the past 5 years, the average E10 Growth Rate was 44.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Integrated Biopharma was 108.00% per year. The lowest was -34.10% per year. And the median was 6.90% per year.

As of today (2026-07-31), Integrated Biopharma's current stock price is $0.16. Integrated Biopharma's E10 for the quarter that ended in Mar. 2026 was $0.09. Integrated Biopharma's Shiller PE Ratio of today is 1.78.

During the past 13 years, the highest Shiller PE Ratio of Integrated Biopharma was 81.00. The lowest was 1.67. And the median was 4.22.


Integrated Biopharma  (OTCPK:INBP) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Integrated Biopharma's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=0.16/0.09
=1.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Integrated Biopharma was 81.00. The lowest was 1.67. And the median was 4.22.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Integrated Biopharma E10 Related Terms


Integrated Biopharma E10 Historical Data

* Premium members only.

The historical data trend for Integrated Biopharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrated Biopharma E10 Chart

Integrated Biopharma Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.08 0.09 0.09 0.09

Integrated Biopharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.09 0.00 0.09 0.09

INBP vs HCWC, PAVS, BABB: E10 Comparison

For the Packaged Foods subindustry, Integrated Biopharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrated Biopharma Shiller PE Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Integrated Biopharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Integrated Biopharma's Shiller PE Ratio falls into.


INBP
36GF Score
Integrated Biopharma Inc INBP
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integrated Biopharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Integrated Biopharma's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.03/330.2130*330.2130
=-0.030

Current CPI (Mar. 2026) = 330.2130.

Integrated Biopharma Quarterly Data

per share eps CPI Adj_EPS
201606 0.040 241.018 0.055
201609 0.030 241.428 0.041
201612 -0.004 241.432 -0.005
201703 0.010 243.801 0.014
201706 0.070 244.955 0.094
201709 -0.010 246.819 -0.013
201712 -0.020 246.524 -0.027
201803 0.010 249.554 0.013
201806 0.028 251.989 0.037
201809 0.010 252.439 0.013
201812 0.010 251.233 0.013
201903 0.030 254.202 0.039
201906 0.010 256.143 0.013
201909 0.010 256.759 0.013
201912 0.030 256.974 0.039
202003 0.030 258.115 0.038
202006 0.060 257.797 0.077
202009 0.030 260.280 0.038
202012 0.040 260.474 0.051
202103 0.040 264.877 0.050
202106 0.140 271.696 0.170
202109 0.020 274.310 0.024
202112 0.030 278.802 0.036
202203 0.030 287.504 0.034
202206 0.050 296.311 0.056
202209 -0.001 296.808 -0.001
202212 -0.010 296.797 -0.011
202303 0.001 301.836 0.001
202306 0.001 305.109 0.001
202309 -0.002 307.789 -0.002
202312 -0.010 306.746 -0.011
202403 0.010 312.332 0.011
202406 0.010 314.175 0.011
202409 0.010 315.301 0.010
202412 0.000 315.605 0.000
202503 0.020 319.799 0.021
202506 -0.010 322.561 -0.010
202509 0.000 324.800 0.000
202512 -0.030 324.054 -0.031
202603 -0.030 330.213 -0.030

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.09 mean?
Integrated Biopharma (INBP) has a E10 of $0.09 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Integrated Biopharma and its competitors.
Is Integrated Biopharma's E10 too high?
Integrated Biopharma's current E10 is $0.09. Overall, Integrated Biopharma has a GF Score™ of 36/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Integrated Biopharma's E10 compare to HCWC and PAVS?
Integrated Biopharma's E10 of $0.09 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Consumer Packaged Goods company?
A good E10 depends on the Consumer Packaged Goods industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Integrated Biopharma and its competitors. Integrated Biopharma's current E10 is $0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrated Biopharma stock overvalued right now?
Based on GuruFocus' analysis, Integrated Biopharma (INBP) is currently considered Possible Value Trap. The stock's GF Value™ is $0.26, compared to a current price of $0.16 — trading 38.5% below its estimated fair value. The current E10 is $0.09. Integrated Biopharma's overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Integrated Biopharma (INBP), the current E10 is $0.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integrated Biopharma (INBP) Overvalued in 2026?

Based on GuruFocus' analysis, Integrated Biopharma stock appears to be undervalued. The current stock price of $0.16 is trading 38.5% below its estimated GF Value™ of $0.26. GuruFocus considers Integrated Biopharma to be Possible Value Trap.

Key valuation signals for INBP:

  • E10: $0.09
  • GF Value™: $0.26 vs. price of $0.16 (38.5% below fair value)
  • GF Score™: 36/100 with 5 warning signs

No single metric tells the full story. See the INBP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Integrated Biopharma Business Description

Address 225 Long Avenue, Building 15, Hillside, NJ, USA, 07205
Integrated Biopharma Inc is a pharmaceutical company engaged in manufacturing, distributing, marketing, and selling vitamins, nutritional supplements, and herbal products. It operates in two segments: Contract Manufacturing and Other Nutraceutical Businesses. Key revenue is generated from the Contract Manufacturing segment, which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.
36GF Score

Get the complete analysis for INBP

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.16
Price
$0.26
GF Value